Vitrolife Balance Sheet Health
Financial Health criteria checks 4/6
Vitrolife has a total shareholder equity of SEK13.2B and total debt of SEK2.0B, which brings its debt-to-equity ratio to 14.9%. Its total assets and total liabilities are SEK16.9B and SEK3.6B respectively. Vitrolife's EBIT is SEK746.0M making its interest coverage ratio 9.6. It has cash and short-term investments of SEK947.0M.
Key information
14.9%
Debt to equity ratio
kr1.98b
Debt
Interest coverage ratio | 9.6x |
Cash | kr947.00m |
Equity | kr13.23b |
Total liabilities | kr3.64b |
Total assets | kr16.87b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: VTFN's short term assets (SEK2.0B) exceed its short term liabilities (SEK556.0M).
Long Term Liabilities: VTFN's short term assets (SEK2.0B) do not cover its long term liabilities (SEK3.1B).
Debt to Equity History and Analysis
Debt Level: VTFN's net debt to equity ratio (7.8%) is considered satisfactory.
Reducing Debt: VTFN's debt to equity ratio has increased from 0% to 14.9% over the past 5 years.
Debt Coverage: VTFN's debt is well covered by operating cash flow (40.3%).
Interest Coverage: VTFN's interest payments on its debt are well covered by EBIT (9.6x coverage).